Jason Baik
About Jason Baik
Jason Baik is a Principal Scientist at ORIC Pharmaceuticals, where he has worked since 2020. He specializes in drug disposition kinetics and manages projects related to the development of small molecule therapeutics for neurodegenerative diseases.
Work at ORIC Pharmaceuticals
Jason Baik has been serving as a Principal Scientist at ORIC Pharmaceuticals since 2020. In this role, he focuses on supporting the development of small molecule therapeutics aimed at treating neurodegenerative diseases. His responsibilities include managing outsourced projects and overseeing drug metabolism and pharmacokinetics (DMPK) activities, which are critical for advancing drug development programs.
Education and Expertise
Jason Baik holds a Ph.D. in Pharmaceutical Sciences from the University of Michigan, where he studied from 2006 to 2012. He also completed a Postdoctoral Fellowship at UCSF in Pharmaceutical Sciences from 2012 to 2014. Prior to this, he earned a Bachelor of Science in Materials (Polymer) Sciences and Engineering from Seoul National University, studying from 1999 to 2005. His expertise includes the translation of drug disposition kinetics through various assessments, including in vitro, in vivo, and in silico methodologies.
Background
Before joining ORIC Pharmaceuticals, Jason Baik held several positions in the pharmaceutical and biotechnology sectors. He worked as a Scientist (Study Director) at Optivia Biotechnology from 2013 to 2016 and as a Postdoctoral Fellow at UCSF from 2012 to 2013. He also served as an Associate Specialist at UCSF for a brief period in 2014. Earlier in his career, he was a Commissioned Research Scientist at the Korea Institute of Science and Technology from 2005 to 2006.
Professional Experience
Jason Baik has accumulated extensive experience in the field of drug development. He worked as a Senior Scientist at ESCAPE Bio from 2019 to 2020. His roles have consistently involved utilizing liquid chromatography-mass spectrometry (LCMS) for pharmacokinetic assessments and bioanalysis, which are essential for understanding drug behavior in biological systems.